Finance

Beta
Lists
CTXR:NASDAQ
Citius Pharmaceuticals Inc
$0.56
-5.00%
(-0.030) 1D
$0.58
+2.80% (+0.016)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTXR...
Open
$0.60
High
$0.61
Low
$0.56
Mkt. cap
15.36M
Avg. vol.
1.02M
Volume
261.84K
52-wk high
$2.48
52-wk low
$0.48
EPS
-$2.59
Beta
1.03
Shares outstanding
27.45M
No. of employees
23
Open
$0.60
High
$0.61
Low
$0.56
Mkt. cap
15.36M
Avg. vol.
1.02M
Volume
261.84K
52-wk high
$2.48
52-wk low
$0.48
EPS
-$2.59
Beta
1.03
Shares outstanding
27.45M
No. of employees
23
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to CTXR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for CTXR in the last 3 months.
Highest
Current $0.56
$4.00 (+614.29%)
Average
$4.00 (+614.29%)
Lowest
$4.00 (+614.29%)
News stories
From sources across the web
About Citius Pharmaceuticals Inc
CEO-
Employees23
Founded2007
HeadquartersCranford, New Jersey, United States
SectorPharmaceutical industry
Websitecitiuspharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
3.94M
1.67M
Cost of goods sold
-
-
789.21K
328.88K
Cost of revenue
-
-
789.21K
328.88K
Research and development expenses
1.62M
1.64M
1.60M
1.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.17M
6.80M
10.00M
30.18M
Operating expense
8.79M
8.44M
11.60M
31.81M
Total operating expenses
8.79M
8.44M
12.39M
32.14M
Operating income
-8.79M
-8.44M
-8.45M
-30.47M
Other non operating income
-
-
-
-
EBT including unusual items
-8.94M
-8.48M
-9.13M
-28.34M
EBT excluding unusual items
-8.94M
-8.48M
-8.56M
-30.45M
Income tax expense
264.24K
264.24K
264.24K
-231.21K
Effective tax rate
-2.96%
-3.12%
-2.89%
0.82%
Other operating expenses
-
-
-
-
Net income
-8.79M
-7.96M
-8.22M
-21.23M
Net profit margin
-
-
-208.43%
-1,273.39%
Earnings per share
-0.80
-0.11
-
-
Interest and investment income
20.64K
53.42K
45.10K
53.58K
Interest expense
-172.26K
-95.52K
-155.54K
-33.03K
Net interest expenses
-151.62K
-42.10K
-110.44K
20.55K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.79M
-8.44M
-7.87M
-28.75M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer